Gerald E Quirk

CIK 1479603 · Chief Legal & Compliance Offic · last filed 2024-11-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

18

Lifetime Open-Market Net

-$10.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SYRS Chief Legal & Compliance Offic 0 $0.00 $0 -$10.3K 13 2024-11-20
Eledon Pharmaceuticals, Inc. (TKAI) Delisted General Counsel, Executive VP $0 2 2015-12-17
INFINITY PHARMACEUTICALS, INC. (INFI) Delisted See Remarks $0.04 $0 3 2012-01-09

Recent Filings · Page 2 of 2

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-02-21 SYRS Grant (A) $0 EDGAR
2017-02-13 SYRS Grant (A) $0 EDGAR
2016-09-29 SYRS Grant (A) $0 EDGAR
2015-12-17 Eledon Pharmaceuticals, Inc. (TKAI) Delisted Grant (A) $0 EDGAR
2015-05-28 Eledon Pharmaceuticals, Inc. (TKAI) Delisted Grant (A) $0 EDGAR
2012-01-09 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) $0 EDGAR
2011-01-07 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) $0 EDGAR
2010-01-07 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) $0 EDGAR
Showing 1118 of 18
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.